European Companies Search Engine

U.S. Securities and Exchange Commission's Electronic Data Gathering, Analysis, and Retrieval system Sec28 Apr 2025 U.S. Securities and Exchange Commission's Electronic Data Gathering, Analysis, and Retrieval system, United States

Text

Entity

entityName Coya Therapeutics, Inc.
Cik 0001835022
Form 10-K/A
Filed 2025-04-28
Fp FY
Fy 2024
Accn 0001193125-25-100816

Facts up to 2025-03-14

Description Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Fact EntityCommonStockSharesOutstanding
Frame CY2025Q1I
Label Entity Common Stock, Shares Outstanding
Taxonomy dei
Unit shares
Val 16,724,998

Facts up to 2024-06-30

Description The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
Fact EntityPublicFloat
Frame CY2024Q2I
Label Entity Public Float
Taxonomy dei
Unit USD
Val 85,212,539

The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Coya Therapeutics Inc., Houston, United States.

Creative Commons License The visualizations for "Coya Therapeutics Inc. - U.S. Securities and Exchange Commission's Electronic Data Gathering, Analysis, and Retrieval system" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.